Meanwhile, various neuronal and glial tau pathologies exist in sCJD patients, including NFT, and the co-existence of Alzheimer’s disease occurs in 10% of patients with sCJD [7, 8]. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.